Status:
UNKNOWN
Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the hepatic perfusion computer tomography and dual energy computer tomography in the assessment of tumor characterization of Hepatocellular carcinoma in patients w...
Detailed Description
Dual-energy computer tomography and perfusion computer tomography (General Electric revolution Hight definition Gemstone™ Spectral Imaging) will be performed in all patients. Iodine concentration and ...
Eligibility Criteria
Inclusion
- A diagnosis of Hepatocellular carcinoma made according to the guidelines of the American Association for the study of the Liver
- Affiliation to a national health insurance
- An indication for hepatic resection during the decision-making stage
- A request for a pre-operative Computer Tomography in our radiology unit
- An affiliation to a social security
- Informed consent given by the patient
Exclusion
- Previous treatments of Hepatocellular carcinoma (medicated or surgical)
- Patient under tutorship or curatorship
- Pregnant or lactating woman
Key Trial Info
Start Date :
January 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03754192
Start Date
January 30 2019
End Date
December 30 2020
Last Update
September 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Paul Brousse
Villejuif, France, 94800